Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
Privia Health Group $936 million secondary offering
We advised Privia on the registered secondary offering
DexCom $1.25 billion convertible notes offering and capped call transactions
The 0.375% convertible senior notes are due 2028
Clarios $750 million notes offering and $2.75 billion term loan
We advised Clarios International on the transactions
Anglo American $900 million notes offering
The 5.500% senior notes are due 2033
Meta Platforms $8.5 billion senior notes offering
We advised Meta on the investment-grade debt offering
Constellation Brands $750 million senior notes offering
The investment-grade notes are due 2033
MedSci Healthcare Holdings HK$608 million IPO
We advised MedSci on its IPO and HKEX listing
ZJLD Group HK$5.3 billion IPO
We advised ZJLD on its IPO and HKEX listing